How Artificial Intelligence Will Transform Genomics

0
160
Artificial Intelligence Will Transform Genomics

Global Artificial Intelligence in Genomics Market: Overview

Solutions from the global artificial intelligence in genomics market are widely used in precision medicine as well as drug discovery branches of the healthcare and pharmaceutical industries. These solutions use various technologies, such as computer vision as well as machine learning. They can also be used for diagnostics purposes in the healthcare industry. The solutions offered by the players in global artificial intelligence in genomics market, both services as well as software, are used to automate or intelligently manage tedious and time consuming tasks in drug discovery processes.  

The market analysis study on the global artificial intelligence in genomics market offers a closer look at the key brand positioning strategies of foremost industry players, volumes of goods produced as well as investments made in recent tactical moves, and the various emerging opportunities in major areas of the application of leading products and services. The research report on the global artificial intelligence in genomics market takes a closer look at the various end-users, different industry segments, and the technological enhancements in production and manufacturing industries. In addition, the analysts offer detailed data points on the growth prospects of various segments and regional segments.

Global Artificial Intelligence in Genomics Market: Factors Likely to Augment Sales

Rising adoption of artificial intelligence technologically enabled solutions in the emerging field of precision medicine, along with rising private as well as public investments in the field of AI in genomics are anticipated to effectively stimulate high growth opportunities in the global artificial intelligence in genomics market over the forecast period i.e. 2021 to 2031. Furthermore, the rising requirement for controlling costs as well as time required for drug and vaccine discovery processes is also propelling the demand in the global artificial intelligence in genomics market. However, dearth of skilled workforce specializing in AI technologies as well as vague and stringent regulations and guidelines pertaining to the development and application of medical software tools and platforms may restrain the global artificial intelligence in genomics market in coming years.

Global Artificial Intelligence in Genomics Market: Regional Assessment

Regionally, North America is anticipated to lead the global artificial intelligence in genomics market in terms of market share, as it did in 2019. This projected trend can be attributed to rising funding as well as government initiatives aimed at boosting the research activities in the industry. Furthermore, government initiatives and investments aimed at promoting the precision medicine practices in the United States is also expected to foster the development trajectory of the North America artificial intelligence in genomics market over the forecast period.

Global Artificial Intelligence in Genomics Market: Key Players and Manufacturer

Leading players in the global artificial intelligence in genomics market include IBM, NVIDIA Corporation, Benevolent AI, Verge Genomics, MolecularMatch, Inc., SOPHiA GENETICS, PrecisionLife Ltd., Lifebit, FDNA, Inc., Empiric Logic, Microsoft, Deep Genomics, Fabric Genomics Inc., Freenome Holdings, Inc., Cambridge Cancer Genomics, Data4Cure Inc., Engine Biosciences Pte. Ltd., Genoox Ltd., Diploid, and DNAnexus Inc. Players and leading participants in the global artificial intelligence in genomics market are focusing on mergers and acquisitions as well as strategic partnerships and collaborations along with new product launches to enhanced their product portfolio as well as expand their consumer base in the industry. For example, NVIDIA Corporation, in October of 2020, announced a partnership with the major player in the global healthcare industry called ‘GSK’. This partnership was done with the AI group of GSK and used to support their team in the United Kingdom to enhance their vaccine and drug discovery processes by using platform offered by NVIDIA

LEAVE A REPLY

Please enter your comment!
Please enter your name here